A Mathematical Model for Predicting Patient Responses to Combined Radiotherapy with CTLA-4 Immune Checkpoint Inhibitors
The purpose of this study was to develop a cell–cell interaction model that could predict a tumor’s response to radiotherapy (RT) combined with CTLA-4 immune checkpoint inhibition (ICI) in patients with hepatocellular carcinoma (HCC). The previously developed model was extended by adding a new term...
Main Authors: | Yongjin Kim, Bo-Young Choe, Tae Suk Suh, Wonmo Sung |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-05-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/12/9/1305 |
Similar Items
-
Impact of CTLA-4 checkpoint antibodies on ligand binding and Transendocytosis
by: Cayman Williams, et al.
Published: (2022-08-01) -
A mathematical modelling tool for unravelling the antibody-mediated effects on CTLA-4 interactions
by: Aravindhan Ganesan, et al.
Published: (2018-06-01) -
Adverse Events and Tolerability of Combined Durvalumab and Tremelimumab versus Durvalumab Alone in Solid Cancers: A Systematic Review and Meta-Analysis
by: Omar Fahmy, et al.
Published: (2022-05-01) -
Evolving Roles for Targeting CTLA-4 in Cancer Immunotherapy
by: Yinghao Zhao, et al.
Published: (2018-05-01) -
Shuffling the deck with CTLA-4 therapy: Deep sequencing of rearranged TCRB genes demonstrates T cell repertoire remodeling in cancer patients
by: Edward Cha, et al.
Published: (2018-04-01)